At the end of a two-year follow-up elevated TSH levels normalize or remain unchanged in most the children with subclinical hypothyroidism by De Luca, Filippo et al.
COMMENTARY Open Access
At the end of a two-year follow-up elevated TSH
levels normalize or remain unchanged in most
the children with subclinical hypothyroidism
Filippo De Luca
1,2*, Malgorzata Wasniewska
1, Giuseppina Zirilli
1, Tommaso Aversa
1, Teresa Arrigo
1
Abstract
Data about the natural evolution of subclinical hypothyroidism (SH) in pediatric age are very scanty. Moreover all
the available reports in both aged and young patients were based on unselected study populations including also
patients with either thyroid disorders or other pathological causes that are well known to be able to affect SH
development and evolution. Aim of the study by Wasniewska et al was to prospectively evaluate for the first time
the natural course of SH in children and adolescents with no underlying diseases and no risk factors that might
interfere with the progression of SH. On the basis of the 2-year follow-up results, the Authors concluded that: a)
the natural course of TSH values in a pediatric population with idiopathic SH is characterized by a progressive
decrease over time; b) the majority of patients (88%) normalized or maintained unchanged their TSH; and c) TSH
changes were not associated with changes of either FT4 values or clinical status or auxological parameters.
Study design of this study is very accurate and the results are robust, thus supporting the Authors’ conclusions.
Introduction
Aim of the present Commentary article is to discuss a
paper concerning the natural course of idiopathic subcli-
nical hypothyroidism (SH) in childhood and adoles-
cence, that has been very recently published [1] and was
included in the 2009 Pediatric Endocrinology Year Book
[2]. Soon after its publication that paper was analyzed
and commented by another Author on another journal
[3].
SH is a condition of moderate thyroid failure charac-
terized by normal circulating levels of thyroid hormones
with mildly elevated TSH serum concentrations. SH is a
common clinical problem in adulthood and elderly, with
an average worldwide prevalence that has been reported
to be in the range of 4-10% in large general population
screening surveys [4] and 7-26% in studies of elderly [5].
In pediatric age SH prevalence seems to be distinctly
lower than in old people, although there are only few
epidemiological studies concerning childhood and ado-
lescence [6-8]. According to one of them, SH frequency
in adolescents is slightly lower than 2% [8-15].
Data from the literature regarding the natural course
of SH are very controversial, probably due to the fact
that most the available longterm studies are retrospec-
tive. Moreover all the available reports on the sponta-
neous evolution of SH in both aged and young patients
have been based, to now, on unselected study popula-
tions including also patients with either thyroid disor-
ders or other pathological causes that are well known to
be able to affect SH development and evolution. The
risk of progression to overt hypothyroidism, in fact, is
known to be greater in those patients with underlying
thyroid diseases [9] and the unfavourable prognostic
value of goiter and thyroid autoantibodies was con-
firmed even in children and adolescents [10]. However,
according to one of the few available follow-up studies
on juvenile SH, this may be a benign and remitting pro-
cess with a very low risk of evolution towards frank
hypothyroidism [11].
In their multicenter study Wasniewska et al [1] have
prospectively evaluated for the first time the natural
course of SH in children and adolescents with no under-
lying diseases and no risk factors that might interfere
with the progression of SH.
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Clinical status, thyroid function, and autoimmunity were
prospectively evaluated at entry and after 6, 12, and 24
months in 92 young patients (mean age 8.1 ± 3.0 years)
with idiopathic SH.
Diagnosis of SH was based on the finding of at least
two consecutive measurements of TSH serum levels
between 5 and 10 μI U / m l ,i nt h ep r e s e n c eo fn o r m a l
FT4 concentrations. In the entire study population all
the etiological causes of SH had been preliminarily
excluded at the time of admission.
During the study mean TSH levels showed a trend
towards a progressive decrease while FT4 levels
remained unchanged. Overall, 38 patients normalized
their TSH (group A): 16 patients between 6 and 12
months, and 22 patients between 12 and 24 months.
Among the remaining 54 patients, the majority main-
tained TSH within the baseline values (group B),
whereas 11 exhibited a further increase in TSH above
10 μIU/ml (group C). Baseline TSH and FT4 levels were
similar in the patients who normalized TSH, compared
with those with persistent hyperthyrotropinemia. Even
in the patients of group C, both TSH and FT4 at entry
were not different with respect to those of group A and
B. No patients showed any symptoms of hypothyroidism
during follow-up and no changes in both height and
body mass index were observed throughout the observa-
tion period.
The Authors concluded that: a) the natural course of
TSH values in a pediatric population with idiopathic SH
is characterized by a progressive decrease over time; b)
the majority of patients (88%) normalized or maintained
unchanged their TSH; c) TSH changes were not asso-
ciated with changes of either FT4 values or clinical sta-
tus or auxological parameters; and d) TSH
determination has no reason to be part of the routine
check up in children, apart from specific protocols.
Conclusions
SH is a very topical problem, which has been frequently
discussed in the last few years by Consensus expert
panels in order to define well-established guidelines for
medical practice and treatment [12-14]. Moreover,
guidelines for SH therapy were frequently discussed in
the last years in a high number of editorials, commen-
taries, controversies or letters to the editor. With regard
to SH treatment, the strategy that is shared by the
majority of experts is to treat individuals with TSH
which is repeatedly higher than 10 μIU/ml. When TSH
is lower than 10 μIU/ml and repeatedly between 4.5 (in
adults) or 5.5 μIU/ml (in prepubertal children), L-T4
therapy is to be considered only in subjects with positive
anti-thyroid antibodies and/or hypothyroid symptoms or
signs, whereas the subjects with idiopathic and asympto-
matic SH should only be checked and periodically
retested [15] a strategy may be considered as appropri-
ate even at the light of the results of the study by Was-
niewska et al, who have clearly demonstrated, through a
2-year follow-up, that in the majority of children with
idiopathic SH elevated TSH levels spontaneously nor-
malize or remain unchanged over time [1]. Due to its
prospective design and the prolonged follow-up, that
study was unique in the context of the studies on juve-
nile SH, as also underlined by Mazzaferri in his com-
mentary (3). The patients were carefully screened for
other causes of SH, including false negative congenital
hypothyroidism. None of the patients had any clinical
signs or symptoms during the entire follow-up. More-
over, none of the patients showed any symptoms of
hypothyroidism during follow-up, and there were no sig-
nificant changes in both height and body mass index
throughout the observation period. The Authors of that
study concluded that the natural course of TSH eleva-
tions in children and adolescents with idiopathic SH is
characterized by a progressive decrease over time and
that the majority of patients have a normalization of
serum TSH within a 2-year follow-up.
To sum up, we agree with Mazzaferri (3) on the fact
that the data in the study by Wasniewska et al (1) are
robust, thus supporting the Authors’ conclusion that
TSH determination has no reason to be part of the rou-
tine check-up in children and adolescents, except for
specific protocols.
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